HealthCap

HealthCap is a leading multi-stage Swedish venture firm based in Stockholm seeking innovative therapeutic ideas that profoundly impact global healthcare. With multiple fund vintages dating back decades, the firm has established itself as one of Europe’s foundational life sciences investors, focusing on biotech, pharma/therapeutics, and life sciences tools companies with breakthrough scientific theses. Their model emphasizes long-horizon engagement with clinical-stage companies, often supporting them across multiple rounds toward exit.

HealthCap invests at Seed, Series A, and Series B, with checks of $1M to $5M as participating investments and larger commitments through follow-on rounds. Geographic scope is European with a Nordic anchor, complemented by transatlantic syndication into US biotechs. They frequently co-invest with leading specialist healthcare funds in Boston, the Bay Area, and continental Europe.

Founders should expect deep scientific diligence and a partner that engages substantively on clinical strategy, regulatory positioning, and downstream syndication. Approach with a clear therapeutic differentiation thesis and credible clinical advisors. Warm introductions through Nordic biotech operators, KOLs, or transatlantic co-investors are the most effective path, and founders should be prepared for multi-meeting evaluation cycles.